Summertime is nearly upon us, which, for many, means kids out of school. This is such a fun time of year – lots of activities ...

The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...